Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John E Burke

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Molecular Cell|September 8, 2018
Structural Basis for Regulation of Phosphoinositide Kinases and Their Involvement in Human DiseaseJohn E Burke
The Journal of Biological Chemistry|January 30, 2019
Dynamic structural biology at the protein membrane interfaceJohn E Burke
Ebiomedicine|January 26, 2020
Molecular insight into the autoinhibition of a master regulator of lipid signalling in human diseaseJohn E Burke
Biochemical Society Transactions|October 31, 2015
Probing the dynamic regulation of peripheral membrane proteins using hydrogen deuterium exchange-MS (HDX-MS)Oscar Vadas, John E Burke
Advances in Biological Regulation|November 18, 2023
Structural basis for the conserved roles of PI4KA and its regulatory partners and their misregulation in diseaseSushant Suresh, John E Burke
Advances in Biological Regulation|October 16, 2019
Class I phosphoinositide 3-kinase (PI3K) regulatory subunits and their roles in signaling and diseaseManoj K Rathinaswamy, John E Burke
Elife|April 1, 2026
Two binding sites are better than oneMackenzie K Scott, John E Burke
Advances in Experimental Medicine and Biology|September 7, 2020
Drugging the Phosphoinositide 3-Kinase (PI3K) and Phosphatidylinositol 4-Kinase (PI4K) Family of Enzymes for Treatment of Cancer, Immune Disorders, and Viral/Parasitic InfectionsJacob A McPhail, John E Burke
Frontiers in Immunology|April 5, 2018
Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-KinasesGillian L Dornan, John E Burke
Cardiovascular Drugs and Therapy|October 22, 2008
Phospholipase A2 biochemistryJohn E Burke, Edward A Dennis
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Molecular Cell|September 8, 2018
Structural Basis for Regulation of Phosphoinositide Kinases and Their Involvement in Human DiseaseJohn E Burke
The Journal of Biological Chemistry|January 30, 2019
Dynamic structural biology at the protein membrane interfaceJohn E Burke
Ebiomedicine|January 26, 2020
Molecular insight into the autoinhibition of a master regulator of lipid signalling in human diseaseJohn E Burke
Biochemical Society Transactions|October 31, 2015
Probing the dynamic regulation of peripheral membrane proteins using hydrogen deuterium exchange-MS (HDX-MS)Oscar Vadas, John E Burke
Advances in Biological Regulation|November 18, 2023
Structural basis for the conserved roles of PI4KA and its regulatory partners and their misregulation in diseaseSushant Suresh, John E Burke
Advances in Biological Regulation|October 16, 2019
Class I phosphoinositide 3-kinase (PI3K) regulatory subunits and their roles in signaling and diseaseManoj K Rathinaswamy, John E Burke
Elife|April 1, 2026
Two binding sites are better than oneMackenzie K Scott, John E Burke
Advances in Experimental Medicine and Biology|September 7, 2020
Drugging the Phosphoinositide 3-Kinase (PI3K) and Phosphatidylinositol 4-Kinase (PI4K) Family of Enzymes for Treatment of Cancer, Immune Disorders, and Viral/Parasitic InfectionsJacob A McPhail, John E Burke
Frontiers in Immunology|April 5, 2018
Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-KinasesGillian L Dornan, John E Burke
Cardiovascular Drugs and Therapy|October 22, 2008
Phospholipase A2 biochemistryJohn E Burke, Edward A Dennis
Pageof 15